Sinil Pharmaceutical Co., Ltd. (KOSDAQ: 012790)

Sinil Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 19, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	72,808	87,711	96,840	128,314	247,300	75,125
Market Cap Growth	7.95%	-9.43%	-24.53%	-48.11%	229.18%	3.30%
Enterprise Value	40,832	69,844	73,664	110,106	234,589	62,957
Last Close Price	6400.00	7710.00	8309.62	10875.82	20765.28	6185.13
PE Ratio	4.91	6.43	7.97	19.21	32.78	10.35
PS Ratio	0.81	0.98	1.21	2.08	4.03	1.24
PB Ratio	0.52	0.65	0.79	1.13	2.30	0.74
P/TBV Ratio	0.59	0.66	0.80	1.15	2.33	0.75
P/FCF Ratio	3.25	56.56	29.03	16.41	109.40	29.17
P/OCF Ratio	3.16	5.79	7.08	11.49	22.36	6.10
EV/Sales Ratio	0.45	0.78	0.92	1.78	3.82	1.04
EV/EBITDA Ratio	1.93	3.61	4.07	8.80	21.22	4.60
EV/EBIT Ratio	2.71	4.99	5.39	13.79	35.43	6.69
EV/FCF Ratio	1.82	45.04	22.08	14.08	103.77	24.44
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.01
Debt / EBITDA Ratio	0.02	0.03	0.01	0.02	0.04	0.04
Debt / FCF Ratio	0.02	0.35	0.04	0.03	0.17	0.20
Asset Turnover	0.59	0.60	0.59	0.49	0.51	0.54
Inventory Turnover	2.20	2.42	2.41	2.22	2.33	2.51
Quick Ratio	3.51	3.27	2.95	3.46	3.44	3.20
Current Ratio	5.00	4.86	4.22	4.86	5.08	4.57
Return on Equity (ROE)	10.98%	10.57%	10.28%	6.05%	7.23%	7.39%
Return on Assets (ROA)	6.10%	5.92%	6.28%	3.93%	3.41%	5.25%
Return on Capital (ROIC)	6.86%	6.76%	7.21%	4.51%	3.95%	5.98%
Earnings Yield	20.37%	15.55%	12.55%	5.21%	3.05%	9.66%
FCF Yield	30.76%	1.77%	3.45%	6.09%	0.91%	3.43%
Payout Ratio	13.04%	8.15%	8.89%	15.73%	14.92%	14.48%
Buyback Yield / Dilution	0.12%	0.04%	-3.91%	0.97%	0.08%	2.92%
Total Shareholder Return	2.78%	0.04%	-3.91%	0.97%	0.08%	2.92%

Source: S&P Capital IQ. Standard template. Financial Sources.